Description

CJC/IPA Blend is a dual-peptide research formulation designed to explore the synergistic effects of growth hormone–releasing pathways. By combining two well-studied compounds with complementary mechanisms of action, this blend supports both the stimulation and regulation of growth hormone release in research models.

In laboratory settings, this combination is commonly evaluated for its potential to:

• Promote growth hormone release and pulsatile activity
• Support recovery and tissue repair processes
• Assist in metabolic and body composition research
• Enhance overall endocrine signaling pathways

CJC and IPA work together to provide a balanced approach to growth hormone research, making this blend a popular option for studies focused on optimizing hormone output and downstream effects.

Key Features:

• Dual-peptide synergistic formulation
• Focused on growth hormone pathway research
• High-purity lyophilized powder
• Consistent and reliable for laboratory applications